A randomized, double-blind, placebo-controlled, ascending, single-dose study of a human monoclonal anti-FGF23 antibody (KRN23) in X-linked hypophosphatemia

Bone Abstracts（2014）

引用 0|浏览1

暂无评分

摘要

Searchable abstracts of presentations at key conferences on calcified tissues ISSN 2052-1219 (online)

查看译文

关键词

antibody,double-blind,placebo-controlled,single-dose,anti-fgf,x-linked

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要